Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:1347-1357
Published online before print September 8, 2008, doi: 10.1161/CIRCULATIONAHA.108.784289
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
118/13/1347    most recent
CIRCULATIONAHA.108.784289v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulz, E.
Right arrow Articles by Keaney, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulz, E.
Right arrow Articles by Keaney, J. F., Jr
Related Collections
Right arrow Energy metabolism
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology
Right arrowRelated Article

(Circulation. 2008;118:1347-1357.)
© 2008 American Heart Association, Inc.


Molecular Cardiology

Suppression of the JNK Pathway by Induction of a Metabolic Stress Response Prevents Vascular Injury and Dysfunction

Eberhard Schulz, MD*; Jörn Dopheide, MD*; Swenja Schuhmacher, BS; Shane R. Thomas, PhD; Kai Chen, MD, PhD; Andreas Daiber, PhD; Philip Wenzel, MD; Thomas Münzel, MD; John F. Keaney, Jr, MD

From the Department of Cardiology, 2nd Medical Clinic of the University Hospital Mainz, Johannes Gutenberg University, Mainz, Germany (E.S., J.D., S.S., A.D., P.W., T.M.), and Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, Mass (S.R.T., K.C., J.F.K.).

Correspondence to Eberhard Schulz, MD, Department of Cardiology, Johannes Gutenberg University, 55101 Mainz, Germany. E-mail dreberhard. schulz{at}nexgo.de

Received April 8, 2008; accepted July 10, 2008.

Background— Oxidative injury and dysfunction of the vascular endothelium are early and causal features of many vascular diseases. Single antioxidant strategies to prevent vascular injury have met with mixed results.

Methods and Results— Here, we report that induction of a metabolic stress response with adenosine monophosphate kinase (AMPK) prevents oxidative endothelial cell injury. This response is characterized by stabilization of the mitochondrion and increased mitochondrial biogenesis, resulting in attenuation of oxidative c-Jun N-terminal kinase (JNK) activation. We report that peroxisome proliferator coactivator 1{alpha} is a key downstream target of AMPK that is both necessary and sufficient for the metabolic stress response and JNK attenuation. Moreover, induction of the metabolic stress response in vivo attenuates reactive oxygen species–mediated JNK activation and endothelial dysfunction in response to angiotensin II in wild-type mice but not in animals lacking either the endothelial isoform of AMPK or peroxisome proliferator coactivator 1{alpha}.

Conclusion— These data highlight AMPK and peroxisome proliferator coactivator 1{alpha} as potential therapeutic targets for the amelioration of endothelial dysfunction and, as a consequence, vascular disease.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 118: 1307-1308. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Ungvari, N. Labinskyy, P. Mukhopadhyay, J. T. Pinto, Z. Bagi, P. Ballabh, C. Zhang, P. Pacher, and A. Csiszar
Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1876 - H1881.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Xu and M.-H. Zou
Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction
Circulation, September 29, 2009; 120(13): 1266 - 1286.
[Full Text] [PDF]


Home page
Circ. Res.Home page
B. Fisslthaler and I. Fleming
Activation and Signaling by the AMP-Activated Protein Kinase in Endothelial Cells
Circ. Res., July 17, 2009; 105(2): 114 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. J. Peterson, D. H. Kim, M. Li, V. Positano, L. Vanella, L. F. Rodella, F. Piccolomini, N. Puri, A. Gastaldelli, C. Kusmic, et al.
The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice
J. Lipid Res., July 1, 2009; 50(7): 1293 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Csiszar, N. Labinskyy, J. T. Pinto, P. Ballabh, H. Zhang, G. Losonczy, K. Pearson, R. de Cabo, P. Pacher, C. Zhang, et al.
Resveratrol induces mitochondrial biogenesis in endothelial cells
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H13 - H20.
[Abstract] [Full Text] [PDF]